Clinical Trial Update: Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of Zonegran (zonisamide) for binge eating disorder associated with obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder
• Obesity

Drugs mentioned

• Zonegran (zonisamide)

Snippet

Sponsor: Lindner Center of HOPE | Conditions: Binge Eating Disorder Associated With Obesity | Phase 3 | Status: COMPLETED